Cargando…

Combined evaluation of coronary artery disease and high-sensitivity cardiac troponin T for prediction of adverse events in patients with hypertrophic cardiomyopathy

BACKGROUND: This study was performed to investigate the clinical significance of combined evaluation of both coronary artery disease (CAD) and high-sensitivity cardiac troponin T (hs-cTnT) for prediction of major adverse cardiovascular events (MACEs) in patients with hypertrophic cardiomyopathy (HCM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Hang, Tan, Huay Cheem, Wang, Ziqiong, Chen, Xiaoping, He, Yong, He, Sen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254350/ https://www.ncbi.nlm.nih.gov/pubmed/34217206 http://dx.doi.org/10.1186/s12872-021-02135-x

Ejemplares similares

Myocardial contraction fraction predicts mortality for patients with hypertrophic cardiomyopathy
por: Liao, Hang, et al.
Publicado: (2020)

U-shaped association between serum uric acid concentration and mortality in hypertrophic cardiomyopathy patients
por: Wang, Ziqiong, et al.
Publicado: (2020)

Elevation of high‐sensitivity cardiac troponin T and left ventricular remodelling in hypertrophic cardiomyopathy
por: Kubo, Toru, et al.
Publicado: (2020)

Relation between lymphocyte to monocyte ratio and survival in patients with hypertrophic cardiomyopathy: a retrospective cohort study
por: Chen, Zhonglan, et al.
Publicado: (2022)

Cardiac Troponin I and T as Prognostic Markers in Cats with Hypertrophic Cardiomyopathy
por: Langhorn, R., et al.
Publicado: (2014)

Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy
por: Hori, Yasutomo, et al.
Publicado: (2018)

Assessing the relationship between systemic immune-inflammation index and mortality in patients with hypertrophic cardiomyopathy
por: Wang, Ziqiong, et al.
Publicado: (2021)

Plasma Cardiac Troponin I Concentration and Cardiac Death in Cats with Hypertrophic Cardiomyopathy
por: Borgeat, K., et al.
Publicado: (2014)

Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study
por: Kubo, Toru, et al.
Publicado: (2015)

Elevated high-sensitivity cardiac troponin is associated with hypertrophy and fibrosis assessed with CMR in patients with hypertrophic cardiomyopathy
por: Gommans, Frank, et al.
Publicado: (2013)

Thromboembolism in Patients with Hypertrophic Cardiomyopathy
por: Liu, Lu, et al.
Publicado: (2021)

Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
por: Marques, Mayra de A., et al.
Publicado: (2016)

Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy
por: Li, Liying, et al.
Publicado: (2023)

Evaluation of a sensitive cardiac troponin I assay as a screening test for the diagnosis of hypertrophic cardiomyopathy in cats
por: Hertzsch, S., et al.
Publicado: (2019)

The impact of hypertension on the prognosis of patients with hypertrophic cardiomyopathy: a single-center retrospective study
por: Wang, Ziqiong, et al.
Publicado: (2023)

Left atrial volume predicts adverse cardiac and cerebrovascular events in patients with hypertrophic cardiomyopathy
por: Tani, Tomoko, et al.
Publicado: (2011)

Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation()
por: Messer, Andrew E., et al.
Publicado: (2016)

Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy
por: Fujita, Etsuko, et al.
Publicado: (2013)

Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy
por: Liu, Limin, et al.
Publicado: (2020)

Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy
por: Fahed, Akl C., et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy Cardiac Troponin C Mutations Differentially Affect Slow Skeletal and Cardiac Muscle Regulation
por: Veltri, Tiago, et al.
Publicado: (2017)

Sexual dimorphism in cardiac transcriptome associated with a troponin C murine model of hypertrophic cardiomyopathy
por: Dieseldorff Jones, Karissa M., et al.
Publicado: (2020)

Anomalous structural dynamics of minimally frustrated residues in cardiac troponin C triggers hypertrophic cardiomyopathy
por: Marques, Mayra A., et al.
Publicado: (2021)

Application of the ALBI Scoring System for Mortality Outcome Prediction in Patients with Hypertrophic Cardiomyopathy
por: Qiao, Ping, et al.
Publicado: (2022)

Painful and painless myocardial ischemia detected by elevated level of high-sensitive troponin in patients with hypertrophic cardiomyopathy
por: Gębka, Adam, et al.
Publicado: (2018)

Use of a highly-sensitive cardiac troponin I assay in a screening population for hypertrophic cardiomyopathy: a case-referent study
por: McGorrian, Catherine M, et al.
Publicado: (2013)

An In Silico Analysis of Troponin I Mutations in Hypertrophic Cardiomyopathy of Indian Origin
por: Ramachandran, Gayatri, et al.
Publicado: (2013)

Reversed Septal Curvature Is Associated with Elevated Troponin Level in Hypertrophic Cardiomyopathy
por: Rajtar-Salwa, Renata, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy Mutations of Troponin Reveal Details of Striated Muscle Regulation
por: Chalovich, J. M., et al.
Publicado: (2022)

Risk factors of sudden cardiac death in hypertrophic cardiomyopathy
por: Hong, Ying, et al.
Publicado: (2022)

Cardiac Troponin Mutations and Restrictive Cardiomyopathy
por: Parvatiyar, Michelle S., et al.
Publicado: (2010)

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene
por: Ehlermann, Philipp, et al.
Publicado: (2008)

The structural and functional effects of the familial hypertrophic cardiomyopathy-linked cardiac troponin C mutation, L29Q
por: Robertson, Ian M., et al.
Publicado: (2015)

Cardiac troponin I in healthy Norwegian Forest Cat, Birman and domestic shorthair cats, and in cats with hypertrophic cardiomyopathy
por: Hanås, Sofia, et al.
Publicado: (2022)

Genetic variation in exon 5 of troponin - I gene in hypertrophic cardiomyopathy cases
por: Annapurna, S. D., et al.
Publicado: (2007)

T2 abnormalities in patients with hypertrophic cardiomyopathy characterized by cardiovascular magnetic resonance imaging- an indicator of myocardial injury as assessed by the high sensitive cardiac troponin T assay
por: Lehrke, Stephanie, et al.
Publicado: (2012)

Prognostic values of highly sensitive cardiac troponin T and B-type natriuretic peptide for clinical features in hypertrophic obstructive cardiomyopathy: a cross-sectional study
por: Nakamura, Shunichi, et al.
Publicado: (2014)

Systolic Compression of Intramural Coronary Arteries in Hypertrophic Cardiomyopathy
por: Sayin, Muhammet Rasit, et al.
Publicado: (2012)

Cardiac Troponin T (TNNT2) Mutations in Chinese Dilated Cardiomyopathy Patients
por: Li, Xiaoping, et al.
Publicado: (2014)

Familial Hypertrophic Cardiomyopathy Related Cardiac Troponin C L29Q Mutation Alters Length-Dependent Activation and Functional Effects of Phosphomimetic Troponin I*
por: Li, Alison Y., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qklk4i3l55h510rpu62s8canmq